Careful planning – Cell and gene therapy IP strategy
Claire Devine and Barbara Fleck discuss the importance of early planning in cell and gene therapy IP strategy.
Who are the players in the digital healthcare space for medicine development? An analysis of patent filing trends
In this article, we look at some of the recent patenting trends and challenges in the digital healthcare space, with a spotlight on digital healthcare for medicine development.
G2/21 – Plausibility
A new EPO referral to the enlarged BoA will determine whether post-filed data can be used to support inventive step and plausibility.
How much data is needed for biotech applications at the EPO?
Claire Devine explains the need for a robust patent filing and prosecution strategy that mitigates against objections for lack of plausibility at the EPO.
Legal and ethical challenges of data-driven healthcare innovation
In the present climate it is clear that there is enormous pressure on healthcare systems across the globe. Further, an increasingly aging population leads to a number of healthcare challenges including that people are living longer generally with one or more chronic conditions.
